A message from our CEO

Dear valued customer,

On Wednesday 11th March the World Health Organization (WHO) declared a pandemic in response to the COVID-19 outbreak. These are very difficult and challenging times for every organization.

HUB greatly values its relationship with its customers and collaborators. We are committed to support you in these challenging times with minimal disruption to your research and clinical studies. We would like to reassure you that we are very closely monitoring the situation with the goal of maintaining our operation and service capacity at the highest level possible, while also protecting the health of our employees.

Currently, all HUB laboratories are operating as normal. We have introduced teams on different shifts in order to maintain safe working conditions while continuing our Organoid Technology services and research to support your drug development programs. If you need more information, please contact us. You can find our contact information on our website.

Sincerely,

Robert Vries

CEO Hubrecht Organoid Technology

March 20, 2020

May 27, 2020 Studying the development of ovarian cancer wi... Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of hig... read more
May 26, 2020 HUB Patient-Derived Organoids added to CrownB... San Diego, Calif – May 19, 2020 — Crown Bioscience today announced the expansion of their unique organoid platform w... read more
May 13, 2020 Hormone-producing cells in the human gut are difficult to study, as they are very rare and unique to different species o... read more